← All stocks

Edesa Biotech, Inc.

EDSA Net buying
CIK 0001540159 #4753 in the set updated 21 Sep 2026
Bought (120 mo)
$1.01M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$903.31K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$903.31K
16 of 16 sales
Net
+$106.29K
+$106.29K against sales at will

By person

16 insiders · 72 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Nijhawan Pardeep
Chief Executive Officer
$429.66K (31)
+$429.66K
6,872,938
$45.35M
+222.4%
van der Velden Peter
10% owner
$450.00K (2)
$787.72K (4)
−$337.72K
2,223,157
$14.67M
+396.5%
Brooks Michael J
President
$84.89K (12)
+$84.89K
291,479
$1.92M
OAKES FRANK R.
Director
$77.22K (5)
−$77.22K
47,924
$316.25K
MORSE DANIEL E.
Former Director
$38.37K (7)
−$38.37K
20,741
$136.87K
JOHNSON LORIN K
Director
$35.03K (1)
+$35.03K
12,786
$84.37K
Sistilli Carlo
Director
$10.01K (1)
+$10.01K
53,071
$350.21K
Weiler Peter J.
Chief Financial Officer
129,609
$855.28K
Marshall Patrick
Director
71,666
$472.92K
MacDonald Sean Arthur
Director
41,054
$270.91K
Chypyha Joan
Director
30,029
$198.16K
+103,448%
Olson Charles V
Director
30,000
$197.97K
Liu Da David
Director
24,501
$161.68K
Lemieux Stephen
Chief Financial Officer
17,400
$114.82K
NIFFENEGGER KATHI
Chief Financial Officer
12,542
$82.76K
+586.5%
Pay Paul William
Director
3,654
$24.11K

No percentages here. This company's share count has moved by a factor of 2.8 over the window, from 3,467,658 to 9,641,031 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
JOHNSON LORIN K
9 Nov 2020
Director
Exercised, kept
4,262
$4.00
$17.05K
NIFFENEGGER KATHI
6 Nov 2020
Chief Financial Officer
Exercised, kept indirect
609
$4.00
$2.44K
Brooks Michael J
6 Nov 2020
President
Exercised, kept
914
$4.00
$3.66K
Pay Paul William
6 Nov 2020
Director
Exercised, kept
1,218
$4.00
$4.87K
Nijhawan Pardeep
5 Nov 2020
Chief Executive Officer
Exercised, kept indirect
4,628
$4.00
$18.51K
Sistilli Carlo
5 Nov 2020
Director
Exercised, kept indirect
1,218
$4.00
$4.87K
van der Velden Peter
2 Nov 2020
Director
Exercised, kept indirect
5,952
$4.00
$23.81K
van der Velden Peter
2 Nov 2020
Director
Exercised, kept indirect
64,362
$4.00
$257.45K
OAKES FRANK R.
6 Oct 2020
Director
Exercised, kept indirect
609
$4.00
$2.44K

What was left out

Form 4 filings counted 206
Amendments (4/A) skipped 13
Filings about a different issuer 0
Unreadable filings 0
Joint filings 26
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 16
Transactions with no price 0
Shares from compensation/vesting 7,726,596
Sales filed before the plan box existed 16
History held since 21 Dec 2016